Combination Chemotherapy, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Newly Diagnosed Large B-Cell Lymphoma

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Centre Antoine Lacassagne

ClinicalTrials.gov Identifier:

NCT00690560

First received: June 3, 2008

Last updated: February 8, 2015

Last verified: February 2015

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2010
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)